Connection

John Gnann to Herpes Zoster

This is a "connection" page, showing publications John Gnann has written about Herpes Zoster.
Connection Strength

2.679
  1. Herpes zoster in the age of focused immunosuppressive therapy. JAMA. 2009 Feb 18; 301(7):774-5.
    View in: PubMed
    Score: 0.313
  2. Vaccination to prevent herpes zoster in older adults. J Pain. 2008 Jan; 9(1 Suppl 1):S31-6.
    View in: PubMed
    Score: 0.289
  3. Clinical practice. Herpes zoster. N Engl J Med. 2002 Aug 01; 347(5):340-6.
    View in: PubMed
    Score: 0.199
  4. Herpes zoster: focus on treatment in older adults. Antiviral Res. 1999 Dec 31; 44(3):145-54.
    View in: PubMed
    Score: 0.166
  5. Herpes zoster: risk categories for persistent pain. J Infect Dis. 1999 Jan; 179(1):9-15.
    View in: PubMed
    Score: 0.155
  6. Therapeutic approaches to the management of herpes zoster. Adv Exp Med Biol. 1999; 458:159-65.
    View in: PubMed
    Score: 0.155
  7. Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster Study Group. Antimicrob Agents Chemother. 1998 May; 42(5):1139-45.
    View in: PubMed
    Score: 0.148
  8. Herpes zoster in patients with human immunodeficiency virus infection--an ever-expanding spectrum of disease. Clin Infect Dis. 1995 Oct; 21(4):989-90.
    View in: PubMed
    Score: 0.124
  9. New antivirals with activity against varicella-zoster virus. Ann Neurol. 1994; 35 Suppl:S69-72.
    View in: PubMed
    Score: 0.110
  10. Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine. J Infect Dis. 2013 Nov 01; 208(9):1386-90.
    View in: PubMed
    Score: 0.106
  11. Safety of zoster vaccine in elderly adults following documented herpes zoster. J Infect Dis. 2013 Aug 15; 208(4):559-63.
    View in: PubMed
    Score: 0.105
  12. Varicella-zoster virus: Prevention through vaccination. Clin Obstet Gynecol. 2012 Jun; 55(2):560-70.
    View in: PubMed
    Score: 0.098
  13. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis. 2012 Apr; 54(7):922-8.
    View in: PubMed
    Score: 0.096
  14. Natural history and treatment of varicella-zoster in high-risk populations. J Hosp Infect. 1991 Jun; 18 Suppl A:317-29.
    View in: PubMed
    Score: 0.092
  15. A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain. 2009 Apr; 142(3):209-217.
    View in: PubMed
    Score: 0.078
  16. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis. 2008 Mar 01; 197 Suppl 2:S207-15.
    View in: PubMed
    Score: 0.073
  17. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain. 2008 Jan; 9(1 Suppl 1):S37-44.
    View in: PubMed
    Score: 0.072
  18. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007 Jan 01; 44 Suppl 1:S1-26.
    View in: PubMed
    Score: 0.067
  19. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005 Jun 02; 352(22):2271-84.
    View in: PubMed
    Score: 0.060
  20. A mixed model for factors predictive of pain in AIDS patients with herpes zoster. J Pain Symptom Manage. 1999 Jun; 17(6):410-7.
    View in: PubMed
    Score: 0.040
  21. Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med. 1996 Sep 01; 125(5):376-83.
    View in: PubMed
    Score: 0.033
  22. Unique clinical trial design: combination acyclovir plus prednisone therapy of localized zoster in the normal host. Antiviral Res. 1996 Jan; 29(1):67-8.
    View in: PubMed
    Score: 0.031
  23. Acyclovir: a decade later. N Engl J Med. 1992 Sep 10; 327(11):782-9.
    View in: PubMed
    Score: 0.025
  24. Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group. J Infect Dis. 1992 Mar; 165(3):450-5.
    View in: PubMed
    Score: 0.024
  25. Acyclovir: the past ten years. Adv Exp Med Biol. 1990; 278:243-53.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.